Construction of a Questionnaire on Panic Disorder and Agoraphobia
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Locations
-
-
North Rhine-Westphalia
-
Witten, North Rhine-Westphalia, Germany, 58455
- Recruiting
- Witten/Herdecke University
-
Contact:
- Ulrike Willutzki, Prof
- Phone Number: +49 (0)2302 / 926-767
- Email: Ulrike.Willutzki@uni-wh.de
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Panic Disorder / Agoraphobia / Depression diagnosis via diagnostic interview
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Panic Disorder / Agoraphobia
Patients with Panic Disorder / Agoraphobia as major diagnosis
|
|
Depression
Patients with Depression as major diagnosis
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Wittener Panik Fragebogen (WPF)
Time Frame: 5 min
|
Self developed panic disorder questionnaire.
Measures panic symptoms on one scale.
Items are averaged.
Range: 1-5.
Higher values represent a worse outcome.
|
5 min
|
|
WAF
Time Frame: 10 min
|
Self developed agoraphobia questionnaire.
Measures agoraphobia symptoms on two scales (Fear and Avoidance).
Items are averaged to calculate the subscales.
Range: 1-5 (Fear); 1-3 (Avoidance).
Higher values represent a worse outcome.
|
10 min
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Agoraphobic Cognition Questionnaire (ACQ)
Time Frame: 5 min
|
Chambless et al. (1985); Ehlers et al. (1993).
The questionnaire measures anxious thoughts on two scales: Loss of Control and Physical Concerns.
Items are averaged to calculate the subscales.
Range: 1-5.
A total score is calculated by averaging all items.
Higher values represent a worse outcome.
|
5 min
|
|
Body Sensations Questionnaire (BSQ)
Time Frame: 5 min
|
Chambless et al. (1985); Ehlers et al. (1993).
The questionnaire measures body sensations that may occur in a feared situation.
Items are averaged to calculate a total score.
Range: 1-5.
Higher values represent a worse outcome.
|
5 min
|
|
Mobility Inventory (MI)
Time Frame: 10 min
|
Chambless et al. (1985); Ehlers et al. (1993).
The questionnaire measures avoidance of agoraphobic situations on two scales (Avoidance Alone and Avoidance Accompanied).
Items are averaged to calculate the scales.
Range: 1-5.
Higher values represent a worse outcome.
|
10 min
|
|
Agoraphobic Self-Statements Questionnaire (ASQ)
Time Frame: 5 min
|
Hout et al. (2001).
Measures agoraphobic statements on two scales (positive self-statements and negative self-statements).
Items are averaged.
Range: 0-4.
Higher values represent a better outcome on the positive scale and a worse outcome on the negative scale.
|
5 min
|
|
Agoraphobic Cognitions Scale - extended version (ACS+)
Time Frame: 5 min
|
Hoffart et al. (1992).
Measures fearful cognitions on three scales (fear of bodily incapacitation, fear of losing control, and fear of acting embarrassingly).
Items are averaged to calculate the scales.
Range: 0-4.
Higher values represent a worse outcome.
|
5 min
|
|
Patient Health Questionnaire - D (PHQ-D) - Subscale Panic Syndrome
Time Frame: 5 min
|
Spitzer, Kroenke & Williams (1999); Löwe et al. (2002).
The questionnaire measures symptoms on modular scales.
The panic syndrome subscale is calculated by summing up all 11 items.
The scale ranges from 0 to 1.
The sum score ranges from 0 to 11.
Higher values represent a worse outcome.
|
5 min
|
|
Brief Symptom Inventory (BSI)
Time Frame: 10 min
|
Derogatis & Melisaratos (1983); Franke (2000).
Measures psychopathological symptoms on nine scales (Somatization, Obsessive-Compulsive, Interpersonal Sensitivity, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation, Psychoticism).
Items are averaged to calculate the subscale scores.
Range: 0-4.
The Global Severity Index (GSI) is calculated by averaging all items.
Higher values represent a worse outcome.
|
10 min
|
|
Beck Depression Inventory (BDI)
Time Frame: 10 min
|
Beck et al. (1961).
Measures depressive symptoms on one scale.
Items summed up to calculate the toal score.
The scale ranges from 0 to 3. The sum score ranges from 0 to 63.
Higher values represent a worse outcome.
|
10 min
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 08/2018
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.